Nursing care
Polycythemia Vera nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Polycythemia vera causes the bone marrow to overproduce red blood cells, making the blood thick and increasing clot risk. Phlebotomy is the primary treatment, hydration is the key teaching point, and pruritus after a hot shower or bath is a distinctive early clue. Nurses should prioritise clot prevention and monitor haematocrit closely.
What it is and why it happens
Polycythemia vera is a myeloproliferative disorder in which the bone marrow produces too many red blood cells, usually driven by a JAK2 gene mutation that makes marrow cells respond to growth signals even without normal stimulation. The result is blood that is measurably thicker than normal, with an elevated haematocrit and often raised white cell and platelet counts alongside it.
That increased viscosity is the mechanism behind almost everything else on this page. Thick blood moves sluggishly, raises the risk of clot formation in both veins and arteries, and forces the heart to work harder to circulate it. Understanding polycythemia vera as a blood-thickness problem, rather than simply a red cell count problem, explains why the treatment is removing volume rather than suppressing the marrow first-line.
How it presents — what you will actually see
The clue experienced nurses learn to ask about is pruritus after a hot shower or bath, caused by histamine release from an increased number of basophils and mast cell activation triggered by the temperature change. Patients often mention it unprompted once you ask directly, describing intense itching with no rash that starts within minutes of warm water contact.
Other findings include a ruddy or plethoric complexion, especially over the face and palms, along with headache, dizziness and blurred vision from the sludging of thick blood through small vessels. Splenomegaly is common and may cause early satiety or left upper quadrant fullness. Some patients present only after a clot, such as a DVT or a stroke, prompting the workup that reveals the underlying disease.
Nursing assessment priorities
Assess for signs of thrombosis at every encounter: calf swelling or tenderness, chest pain, sudden shortness of breath, and any new neurological symptom all need immediate attention in a patient with known or suspected polycythemia vera. This population carries a meaningfully elevated risk of both venous and arterial clotting compared with the general population.
Track haematocrit and haemoglobin trends closely, since these values guide phlebotomy frequency. Ask specifically about pruritus, headache and visual changes, as patients may not volunteer symptoms they've learned to live with. Check for splenomegaly on abdominal exam and monitor blood pressure, since hypertension is common and compounds cardiovascular risk.
Interventions and what to do first
Therapeutic phlebotomy is the first-line treatment and the intervention nurses will perform or assist with most often. Removing 250 to 500 mL of blood reduces red cell mass directly and provides rapid symptomatic relief, with the target haematocrit typically kept below 45%. Frequency starts more often early in treatment and spaces out once the target is reached.
Low-dose aspirin is commonly prescribed to reduce clot risk unless contraindicated, and cytoreductive therapy such as hydroxyurea may be added for higher-risk patients or those who don't tolerate phlebotomy alone. Encourage ambulation and adequate hydration during any hospital stay to further reduce clot risk, and avoid iron supplementation, since iron deficiency from phlebotomy is expected and desirable, not a problem to correct.
Complications to watch for
Thrombosis is the leading cause of morbidity and mortality in polycythemia vera, and it can occur in unusual locations such as the hepatic or portal veins in addition to the more familiar DVT, pulmonary embolism, and stroke. Any new abdominal pain in this patient population deserves a lower threshold for investigation than usual.
Bleeding is a paradoxical but real risk, particularly when platelet counts are very high, since abnormally functioning platelets can impair clotting despite the high count. Over time, a minority of patients progress to myelofibrosis or acute leukaemia, so long-term follow-up and blood count monitoring continue even when symptoms are well controlled.
Patient teaching before discharge
Hydration is the central teaching point for daily life with polycythemia vera. Encourage patients to drink adequate fluids consistently, since dehydration further concentrates already thick blood and raises clot risk. Pair this with practical advice on avoiding prolonged immobility, such as moving regularly on long flights or car journeys.
Teach patients to recognise and report symptoms of clotting immediately, including leg swelling, chest pain, sudden headache, or vision changes. For the pruritus, suggest lukewarm rather than hot water for bathing and patting rather than rubbing the skin dry, since both reduce the histamine trigger. Reinforce the importance of attending scheduled phlebotomy appointments even when feeling well, since haematocrit control is what prevents complications.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our med-surg practice questions are the closest set to what this page covers.
One question from the med-surg set
A client with chronic obstructive pulmonary disease has an oxygen saturation of 88% on 2 L/min via nasal cannula and is alert with no distress. What should the nurse do first?
Rationale
In COPD a saturation of 88–92% is the therapeutic target, not an emergency, and this client is alert with no distress. The first action is the independent nursing intervention that is least invasive and most likely to help: sit them up and reassess. Turning the oxygen up to 6 L/min risks blunting the hypoxic drive, and calling rapid response or drawing an ABG escalates ahead of an assessment you have not finished.
Answer: B
Common questions
Why does hot water cause itching in polycythemia vera?
Warm water triggers histamine release from an increased number of basophils and activates mast cells in patients with polycythemia vera, producing intense itching without a visible rash. It's one of the more specific clinical clues for the disease and worth asking about directly during assessment.
What is the target haematocrit for phlebotomy in polycythemia vera?
A haematocrit below 45% is the commonly used target for most adults with polycythemia vera, since maintaining it under this threshold has been shown to reduce cardiovascular events. Individual targets can vary, so always follow the prescribed plan rather than a fixed number.
Should iron supplements be given after phlebotomy in polycythemia vera?
No. Phlebotomy intentionally induces a degree of iron deficiency, which helps limit red cell production, so iron supplementation is avoided unless the patient develops symptomatic anaemia unrelated to the treatment plan. This is a common point of confusion since iron deficiency is treated in almost every other context.
What NCLEX-style question pattern comes up for polycythemia vera?
Expect questions asking you to prioritise thrombosis assessment, identify phlebotomy as the correct first-line intervention over medication, and recognise pruritus after bathing as a classic symptom. Questions may also test whether you'd correct a distractor answer suggesting iron supplementation after phlebotomy.
Why is aspirin used in polycythemia vera if bleeding risk exists too?
Low-dose aspirin is used to reduce the higher overall risk of arterial and venous thrombosis in polycythemia vera, which for most patients outweighs the bleeding risk from platelet dysfunction. It is withheld or reconsidered in patients with very high platelet counts or a prior bleeding history, so the decision is individualised.
More on med-surg